These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2308159)

  • 21. Molecular genetics in the National Health Service in Britain.
    Harris R; Elles R; Craufurd D; Dodge A; Ivinson A; Hodgkinson K; Mountford R; Schwartz M; Strachan T; Read A
    J Med Genet; 1989 Apr; 26(4):219-25. PubMed ID: 2523972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genotypic diagnosis of Duchenne and Becker muscular dystrophies].
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Ann Biol Clin (Paris); 1999; 57(4):417-26. PubMed ID: 10432364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience and strategy for the molecular testing of Duchenne muscular dystrophy.
    Prior TW; Bridgeman SJ
    J Mol Diagn; 2005 Aug; 7(3):317-26. PubMed ID: 16049303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular biology in genetic counseling of Duchenne and Becker myopathy].
    Philip N; Voelckel MA; Girardot L; Lambert JC; Moncla A; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):821-8. PubMed ID: 1338927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis of Duchenne and Becker muscular dystrophies: Underestimated problem of the secondary prevention of monogenetic disorders.
    Massalska D; Zimowski JG; Roszkowski T; Bijok J; Pawelec M; Bednarska-Makaruk M
    J Obstet Gynaecol Res; 2017 Jul; 43(7):1111-1121. PubMed ID: 28561990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular-genetic study of Duchenne and Becker muscular dystrophies: deletion analyses of 45 Japanese patients and segregation analyses in their families with RFLPs based on the data from normal Japanese females.
    Sugino S; Fujishita S; Kamimura N; Matsumoto T; Wapenaar MC; Deng HX; Shibuya N; Miike T; Niikawa N
    Am J Med Genet; 1989 Dec; 34(4):555-61. PubMed ID: 2576185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis, genetics, and DNA technology.
    Nugent CE
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):235-41. PubMed ID: 1912355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a closely linked polymorphism of restriction fragment length to counselling and prenatal testing in families with myotonic dystrophy.
    Meredith AL; Huson SM; Lunt PW; Sarfarazi M; Harley HG; Brook JD; Shaw DJ; Harper PS
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1353-6. PubMed ID: 2878705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    Darras BT; Harper JF; Francke U
    N Engl J Med; 1987 Apr; 316(16):985-92. PubMed ID: 3561454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The resource implications and service outcomes of genetic services in the context of DNA technology.
    Beech R; Rona RJ; Mandalia S
    Health Policy; 1994 Jan; 26(3):171-90. PubMed ID: 10133130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successes and prospects of molecular diagnosis of the most widespread inherited diseases].
    Baranov VS
    Tsitol Genet; 1992; 26(4):64-72. PubMed ID: 1440921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic screening for the next decade: application of present and new technologies.
    McCabe ER
    Yale J Biol Med; 1991; 64(1):9-14. PubMed ID: 1680260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal diagnosis of Duchenne and Becker muscular dystrophy.
    Abbs S
    Prenat Diagn; 1996 Dec; 16(13):1187-98. PubMed ID: 9061750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the molecular genetics of Duchenne muscular dystrophy.
    Siddique T; Bartlett R; Pericak-Vance M; Yamaoka L; Koh J; Chen J; Hung WY; Kandt R; Roses AD
    Aust Paediatr J; 1988; 24 Suppl 1():9-14. PubMed ID: 3060079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 37. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal diagnosis of congenital myopathies and muscular dystrophies.
    Massalska D; Zimowski JG; Bijok J; Kucińska-Chahwan A; Łusakowska A; Jakiel G; Roszkowski T
    Clin Genet; 2016 Sep; 90(3):199-210. PubMed ID: 27197572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.
    Darras BT; Koenig M; Kunkel LM; Francke U
    Am J Med Genet; 1988 Mar; 29(3):713-26. PubMed ID: 2897793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Principles of DNA diagnosis].
    Moser H
    Klin Monbl Augenheilkd; 1990 May; 196(5):265-8. PubMed ID: 2366450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.